1. Gera S, Dekmezian MS, Duvic M, Tschen JA, Vega F, Cho-Vega JH. Blastic plasmacytoid dendritic cell neoplasm: evolving insights in an aggressive hematopoietic malignancy with a predilection of skin involvement. Am J Dermatopathol. 2014; 36:244–251.
2. Adachi M, Maeda K, Takekawa M, Hinoda Y, Imai K, Sugiyama S, et al. High expression of CD56 (N-CAM) in a patient with cutaneous CD4-positive lymphoma. Am J Hematol. 1994; 47:278–282.
![crossref](/image/icon/bnr_ref_cross.gif)
3. Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH, et al. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005; 105:3768–3785.
![crossref](/image/icon/bnr_ref_cross.gif)
4. Shi Y, Wang E. Blastic plasmacytoid dendritic cell neoplasm: a clinicopathologic review. Arch Pathol Lab Med. 2014; 138:564–569.
![crossref](/image/icon/bnr_ref_cross.gif)
5. Chan J, Jaffe ES, Ralfkiaer E. Blastic NK-cell lymphoma. In : Jaffe ES, Harris NL, Stein H, Vardiman J, editors. WHO classification of tumors pathology & genetics tumours of haematopoietic and lymphoid tissue. London: IARC press;2001. p. 22–25.
6. Facchetti F, Jones D, Petrella T. Blastic plasmacytoid dendritic cells neoplasm. In : Swerdlow SH, Campo E, Harris N, Jaffe E, Pileri S, Stein H, editors. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon, France: IARC Press;2008. p. 146–147.
7. Pagano L, Valentini CG, Pulsoni A, Fisogni S, Carluccio P, Mannelli F, et al. GIMEMA-ALWP (Gruppo Italiano Malattie EMatologiche dell'Adulto, Acute Leukemia Working Party). Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study. Haematologica. 2013; 98:239–246.
![crossref](/image/icon/bnr_ref_cross.gif)
8. Bueno C, Almeida J, Lucio P, Marco J, Garcia R, de Pablos JM, et al. Incidence and characteristics of CD4(+)/HLA DRhi dendritic cell malignancies. Haematologica. 2004; 89:58–69.
9. Ng AP, Lade S, Rutherford T, McCormack C, Prince HM, Westerman DA. Primary cutaneous CD4+/CD56+ hematodermic neoplasm (blastic NK-cell lymphoma): a report of five cases. Haematologica. 2006; 91(1):143–144.
10. Julia F, Petrella T, Beylot-Barry M, Bagot M, Lipsker D, Machet L, et al. Blastic plasmacytoid dendritic cell neoplasm: clinical features in 90 patients. Br J Dermatol. 2013; 169:579–586.
![crossref](/image/icon/bnr_ref_cross.gif)
11. Dalle S, Beylot-Barry M, Bagot M, Lipsker D, Machet L, Joly P, et al. Blastic plasmacytoid dendritic cell neoplasm: is transplantation the treatment of choice? Br J Dermatol. 2010; 162:74–79.
![crossref](/image/icon/bnr_ref_cross.gif)
12. Petrella T, Bagot M, Willemze R, Beylot-Barry M, Vergier B, Delaunay M, et al. Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms): a review. Am J Clin Pathol. 2005; 123:662–675.
![crossref](/image/icon/bnr_ref_cross.gif)
13. Cota C, Vale E, Viana I, Requena L, Ferrara G, Anemona L, et al. Cutaneous manifestations of blastic plasmacytoid dendritic cell neoplasm-morphologic and phenotypic variability in a series of 33 patients. Am J Surg Pathol. 2010; 34:75–87.
![crossref](/image/icon/bnr_ref_cross.gif)
14. Jegalian AG, Buxbaum NP, Facchetti F, Raffeld M, Pittaluga S, Wayne AS, et al. Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical implications. Haematologica. 2010; 95:1873–1879.
![crossref](/image/icon/bnr_ref_cross.gif)
15. Hamada T, Iwatsuki K. Cutaneous lymphoma in Japan: a nationwide study of 1733 patients. J Dermatol. 2014; 41:3–10.
![crossref](/image/icon/bnr_ref_cross.gif)
16. An HJ, Yoon DH, Kim S, Shin SJ, Huh J, Lee KH, et al. Blastic plasmacytoid dendritic cell neoplasm: a single-center experience. Ann Hematol. 2013; 92:351–356.
![crossref](/image/icon/bnr_ref_cross.gif)
17. Rauh MJ, Rahman F, Good D, Silverman J, Brennan MK, Dimov N, et al. Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation, lacking cutaneous involvement: Case series and literature review. Leuk Res. 2012; 36:81–86.
![crossref](/image/icon/bnr_ref_cross.gif)
18. Borchiellini D, Ghibaudo N, Mounier N, Del Giudice P, Quinsat D, Ticchioni M, et al. Blastic plasmacytoid dendritic cell neoplasm: a report of four cases and review of the literature. J Eur Acad Dermatol Venereol. 2013; 27:1176–1181.
![crossref](/image/icon/bnr_ref_cross.gif)
19. Argyrakos T, Rontogianni D, Karmiris T, Kapsimali V, Grigoriou E, Tsantekidou M, et al. Blastic natural killer (NK)-cell lymphoma: report of an unusual CD4 negative case and review of the CD4 negative neoplasms with blastic features in the literature. Leuk Lymphoma. 2004; 45:2127–2133.
![crossref](/image/icon/bnr_ref_cross.gif)
20. Petrella T, Teitell MA, Spiekermann C, Meijer CJ, Franck F, Enache I. A CD56-negative case of blastic natural killer-cell lymphoma (agranular CD4+/CD56+ haematodermic neoplasm). Br J Dermatol. 2004; 150:174–176.
![crossref](/image/icon/bnr_ref_cross.gif)
21. Tsagarakis NJ, Kentrou NA, Papadimitriou KA, Pagoni M, Kokkini G, Papadaki H, et al. Hellenic Dendritic Cell Leukemia Study Group. Acute lymphoplasmacytoid dendritic cell (DC2) leukemia: results from the Hellenic Dendritic Cell Leukemia Study Group. Leuk Res. 2010; 34:438–446.
![crossref](/image/icon/bnr_ref_cross.gif)
22. Leroux D, Mugneret F, Callanan M, Radford-Weiss I, Dastugue N, Feuillard J, et al. CD4(+), CD56(+) DC2 acute leukemia is characterized by recurrent clonal chromosomal changes affecting 6 major targets: a study of 21 cases by the Groupe Français de Cytogénétique Hématologique. Blood. 2002; 99:4154–4159.
![crossref](/image/icon/bnr_ref_cross.gif)
23. Dijkman R, van Doorn R, Szuhai K, Willemze R, Vermeer MH, Tensen CP. Gene-expression profiling and array-based CGH classify CD4+CD56+ hematodermic neoplasm and cutaneous myelomonocytic leukemia as distinct disease entities. Blood. 2007; 109:1720–1727.
![crossref](/image/icon/bnr_ref_cross.gif)
24. Lucioni M, Novara F, Fiandrino G, Riboni R, Fanoni D, Arra M, et al. Twenty-one cases of blastic plasmacytoid dendritic cell neoplasm: focus on biallelic locus 9p21.3 deletion. Blood. 2011; 118:4591–4594.
![crossref](/image/icon/bnr_ref_cross.gif)
25. Roos-Weil D, Dietrich S, Boumendil A, Polge E, Bron D, Carreras E, et al. European Group for Blood and Marrow Transplantation Lymphoma, Pediatric Diseases, and Acute Leukemia Working Parties. Stem cell transplantation can provide durable disease control in blastic plasmacytoid dendritic cell neoplasm: a retrospective study from the European Group for Blood and Marrow Transplantation. Blood. 2013; 121:440–446.
![crossref](/image/icon/bnr_ref_cross.gif)
26. Ferrándiz-Pulido C, López-Lerma I, Sábado C, Ferrer B, Pisa S, García-Patos V. Blastic plasmacytoid dendritic cell neoplasm in a child. J Am Acad Dermatol. 2012; 66:e238–e240.
![crossref](/image/icon/bnr_ref_cross.gif)
27. Ham JC, Janssen JJ, Boers JE, Kluin PM, Verdonck LF. Allogeneic stem-cell transplantation for blastic plasmacytoid dendritic cell neoplasm. J Clin Oncol. 2012; 30:e102–e103.
![crossref](/image/icon/bnr_ref_cross.gif)
28. Reimer P, Rüdiger T, Kraemer D, Kunzmann V, Weissinger F, Zettl A, et al. What is CD4+CD56+ malignancy and how should it be treated? Bone Marrow Transplant. 2003; 32:637–646.
![crossref](/image/icon/bnr_ref_cross.gif)
29. Suzuki R, Nakamura S, Suzumiya J, Ichimura K, Ichikawa M, Ogata K, et al. NK-cell Tumor Study Group. Blastic natural killer cell lymphoma/leukemia (CD56-positive blastic tumor): prognostication and categorization according to anatomic sites of involvement. Cancer. 2005; 104:1022–1031.
![crossref](/image/icon/bnr_ref_cross.gif)
30. Bekkenk MW, Jansen PM, Meijer CJ, Willemze R. CD56+ hematological neoplasms presenting in the skin: a retrospective analysis of 23 new cases and 130 cases from the literature. Ann Oncol. 2004; 15:1097–1108.
![crossref](/image/icon/bnr_ref_cross.gif)